In Alberta, since 2007, we have been transplanting HCC patients using a total tumour volume (TTV) of ≤115 cm3 and alpha-fetoprotein (AFP) ≤400 ng/mL as selection criteria [15, 16]. Here, AFP is linked to hepatocellular carcinoma.